Specialty code 390200000X · Tempe, AZ
NPI
1679120547
Since 2019
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
801 E McKellips Rd Apt 18a
Tempe, AZ, 85281
Phone (918) 801-5226
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.6M
4,434 prescriptions
Company payments, 2025
$1,640
From 24 companies
Medicare prescription drug claims, 2024
In 2024, the drug Julie A Linn prescribed most often to Medicare patients was Levothyroxine Sodium, with 455 prescriptions and refills. In total Julie A Linn wrote 4,434 Medicare prescriptions that cost $3.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 455 | 1,204 | 151 | $4,144 |
| Ozempic Semaglutide | 334 | 610 | 90 | $581K |
| Metformin Hcl Generic | 203 | 529 | 73 | $1,920 |
| Jardiance Empagliflozin | 200 | 398 | 68 | $229K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 198 | 413 | 73 | $31K |
| Trulicity Dulaglutide | 163 | 302 | 51 | $297K |
| Metformin Hcl Er Metformin Hcl | 124 | 366 | 46 | $1,528 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 120 | 317 | 57 | $16K |
| Synthroid Levothyroxine Sodium | 105 | 283 | 29 | $7,747 |
| Glimepiride Generic | 98 | 242 | 37 | $889 |
| Mounjaro Tirzepatide | 94 | 129 | 31 | $142K |
| Humalog Kwikpen U-100 Insulin Lispro | 89 | 179 | 35 | $26K |
| Atorvastatin Calcium Generic | 87 | 227 | 30 | $946 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 78 | 123 | 20 | $76K |
| Tresiba Flextouch U-100 Insulin Degludec | 70 | 151 | 28 | $69K |
Brand drugs: 2,417 claims; generic drugs: 1,647 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie A Linn $1,640 ($1,640 in general payments such as food, travel and fees) from 24 companies. The largest payer was Lilly USA, LLC with $208.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 16 | $208 |
| Novo Nordisk Inc NVO | 11 | $206 |
| Amgen Inc. AMGN | 14 | $205 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $99.83 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $90.64 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $88.72 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $73.04 |
| Xeris Pharmaceuticals, Inc. | 4 | $72.29 |
| Insulet Corporation PODD | 3 | $65.81 |
| Recordati_rare_diseases_inc. | 2 | $59.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.